Evidence map›Paper›PMID 41345579›Full record

ArticleBMC infectious diseases2025

Whole genome sequencing of Neisseria gonorrhoeae among key populations in two cities of Bangladesh reveals genomic diversity and stable antimicrobial resistance.

Muntasir Alam, Arpita Shyama Deb, Zahidul Islam, Golam Sarwar, Md Masud Reza, Md Safiullah Sarker, Sharful Islam Khan, Mustafizur Rahman

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Muntasir AlamInternational Centre for Diarrhoeal Diseases Research, Bangladesh, 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka, 1212, Bangladesh.
Arpita Shyama DebInternational Centre for Diarrhoeal Diseases Research, Bangladesh, 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka, 1212, Bangladesh.
Zahidul IslamInternational Centre for Diarrhoeal Diseases Research, Bangladesh, 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka, 1212, Bangladesh.
Golam SarwarInternational Centre for Diarrhoeal Diseases Research, Bangladesh, 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka, 1212, Bangladesh.
Md Masud RezaInternational Centre for Diarrhoeal Diseases Research, Bangladesh, 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka, 1212, Bangladesh.
Md Safiullah SarkerInternational Centre for Diarrhoeal Diseases Research, Bangladesh, 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka, 1212, Bangladesh.
Sharful Islam Khan *International Centre for Diarrhoeal Diseases Research, Bangladesh, 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka, 1212, Bangladesh.
Mustafizur Rahman *International Centre for Diarrhoeal Diseases Research, Bangladesh, 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka, 1212, Bangladesh. mustafizur@icddrb.org.

Funding

Department of Foreign Affairs, Trade and Development (DFATD), Canada 02063
6 · The paper itself

Abstract

backgroundNeisseria gonorrhoeae is an obligate human pathogen causing gonorrhea the second most reported bacterial sexually transmitted infection. High level genomic plasticity of this pathogen requires whole genome sequence (WGS) analysis for epidemiological investigations. The absence of N. gonorrhoeae genomic data from Bangladesh represents a critical gap in South Asian gonococcal genomic epidemiology. Here we report, a genomic investigation of N. gonorrhoeae from Bangladesh using WGS approach.

methodsTwenty-four N. gonorrhoeae isolates were collected from key populations including female sex workers, male sex workers and Hijra. These belong to two studies conducted in two districts of Bangladesh; a cross-sectional bio-behavioral survey 2014 (Dhaka) and sexual and reproductive health and rights 2022–2024 (Dhaka and Jashore). Antibiotic resistance data from disc-diffusion assay were available from specific study. Recovered isolates were sequenced using Illumina NextSeq550 instrument. Sequence typing, presence of virulence genes and antimicrobial resistance genes/mutations were determined using PubMLST, Pathogenwatch, and ABRicate. Phylogenetic analysis was conducted using maximum likelihood method with globally reported selected sequences as well as WHO reference sequences.

resultsGenomic analysis for MLST revealed nine sequence types, with ST7363 predominating in 50% (12/24) of isolates, particularly among male sex workers (58.3%; 7/12). Novel NG-STAR types comprised 33.3% (8/24) of isolates, while novel NG-MAST types reached 62.5% (15/24). Genomic analysis predicted resistance to ciprofloxacin (100%), sulfonamides (91.7%) and tetracycline (79.2%), while 100% sensitivity was predicted for azithromycin, ceftriaxone and spectinomycin. Phylogenetic analysis showed four intra clusters for 18 isolates and 6 were distributed separately.

conclusionsHere we report, genomic diversity of N. gonorrhoeae from Bangladeshi key populations predicting relatively stable antibiotic susceptibility pattern in comparison to previous studies. These findings emphasize the urgent need for genomic surveillance and antimicrobial stewardship in Bangladesh to preserve current treatment options.

Indexed as

Drug Resistance, BacterialGenetic VariationGonorrheaNeisseria gonorrhoeaeWhole Genome SequencingAdultAnti-Bacterial AgentsBangladeshCitiesCross-Sectional StudiesFemaleGenome, BacterialHumansMaleMicrobial Sensitivity TestsMultilocus Sequence TypingAnti-Bacterial AgentsThird Generation CephalosporinsBangladeshKey populationNeisseria gonorrhoeaeSexual and reproductive health and rightsSRHRWhole genome sequencing

Identifiers

PMID41345579
PMCPMC12781483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.